I'm A Breast Cancer Doctor. Here's What I Didn't Know — Until I Was Diagnosed Myself.
Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...
pharmaphorum3h
AZ, Daiichi get FDA nod for Dato-DXd in breast cancer
The US regulator has cleared TROP2-directed ADC datopotamab deruxtecan (Dato-DXd) under the Datroway trade name as a ...
New breast cancer drug given green light for NHS use
Breast Cancer Now said olaparib will be an ‘valuable alternative’ for patients with a certain type of secondary breast cancer ...
Bayer menopause drug reduces hot flashes in breast cancer group
Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the ...
TiLoop Mesh implant offers hope & healing to breast cancer patient
Bengaluru: For Latha (name changed), a 37-year-old woman diagnosed with breast cancer in April 2024, the news of her illness ...
Hosted on MSN4d
Breast Cancer: What It Is, Symptoms, Types, Stages & Treatments
Susan G. Komen: Quality of Life After Breast Cancer Treatment. National Cancer Institute: Complementary and Alternative ...
DATROWAY® (datopotamab deruxtecan-dlnk) approved in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
DATROWAY® (datopotamab deruxtecan-dlnk) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative (IHC 0, IHC 1+ or ...
DATROWAY® Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
DATROWAY Approved in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer ...